We can’t show the full text here under this license.
EBioMedicine···
Using imaging to measure how drugs bind to incretin receptors in the body and brain
Updated
Abstract
SAR441255 achieved >70% GLP-1R occupancy in the pancreas and pituitary in vivo.
- Two tracers demonstrated high specificity for GLP-1R and GIPR in vitro.
- In vivo studies indicated SAR441255 led to dose-dependent GLP-1R occupancy greater than 70% in specific brain regions.
- Tirzepatide exhibited lower GLP-1R occupancy compared to SAR441255.
- SAR441255 reduced pancreatic uptake of a GIPR tracer by 23 ± 8.5%, suggesting GIPR engagement.
Simplified
BACKGROUND: Incretin mimetics, especially dual/triple agonists, are effective for type 2 diabetes and obesity, though mechanisms remain unclear. This study applied PET using [Ga]Ga-DO3A-Exendin-4 and [Ga]S02-GIP-T4 to assess GLP-1R and GIPR occupancy of SAR441255 (a GLP-1R, GIPR, and GCGR agonist) and tirzepatide in pig pancreas and CNS. 68 68
METHODS: In vitro binding assays on frozen HEK293 cell sections overexpressing human GLP-1R, GIPR, or GCGR assessed [Ga]Ga-DO3A-Exendin-4 specificity and competition with tirzepatide and SAR441255, and [Ga]S02-GIP-T4 with SAR441255. In vivo, the GLP-1R occupancy by SAR441255 and tirzepatide, and GIPR occupancy by SAR441255, was evaluated in healthy pigs using PET/CT initiated at tracer injection. A subcutaneous dose of the study drug was then administered, and a second scan was performed 2.5 h later. Occupancy was determined by comparing pancreatic and CNS tracer SUV before and after dosing. Two animals were used to compare the tracers directly. 68 68
FINDINGS: [Ga]Ga-DO3A-Exendin-4 and [Ga]S02-GIP-T4 showed high specificity for GLP-1R and GIPR, respectively, and competed with the study drugs in vitro. In vivo, SAR441255 induced dose-dependent GLP-1R occupancy (>70%) in pancreas and pituitary and (>60%) in CNS, while tirzepatide showed lower occupancy. SAR441255 also reduced pancreatic [Ga]S02-GIP-T4 uptake by 23 ± 8.5%, indicating GIPR engagement. 68 68 68
INTERPRETATION: PET imaging in pigs demonstrated in vivo GLP-1R engagement by SAR441255 and tirzepatide, and GIPR engagement by SAR441255 in the pancreas. SAR441255 exhibited dose-dependent GLP-1R occupancy in the pancreas and brain regions linked to appetite regulation.
FUNDING: The study was funded by Uppsala Diabetes Center, Diabetesfonden, ExoDiab, Diabetes Wellness Sweden, Barndiabetesfonden, Science for Life Laboratory, and the Swedish Research Council.
Related papers
Feb '21
Measuring How a Drug Binds to the Glucose-Dependent Insulinotropic Polypeptide Receptor Using PET Scans
top 5% journal
cited by 11 papers
research support, non-u.s. gov't
Jan '24
Adding a fatty acid chain to extend the blood lifespan of a molecule targeting the glucose-dependent insulin receptor
top 30% journal
cited by 4 papers
research support, non-u.s. gov't
Jun '13
Imaging a key hormone receptor in the pancreas using a special radioactive tracer
cited by 83 papers
research support, non-u.s. gov't
Dec '21
Weight loss and blood sugar control with SAR441255, a drug activating three hormone receptors
top 1% journal
cited by 161 papers
research support, non-u.s. gov't
May '20
Drug effects of single, double, and triple peptide activators on GIP and GLP-1 hormone receptors
top 10% journal
cited by 51 papers
research support, non-u.s. gov't
Feb '25
Mice missing one incretin receptor do not increase secretion of the other hormone after glucose
top 10% journal
journal article
Mar '14
Imaging the GLP-1 receptor in healthy and diabetic pigs
top 5% journal
cited by 39 papers
research support, n.i.h., extramural
Apr '21
Mapping GLP-1 and Its Receptor in Pig Pancreas and Digestive Tract Using Tissue Imaging
top 10% journal
cited by 4 papers
research support, non-u.s. gov't
Aug '25
How a new dual GLP-1 and GIP receptor activator binds, signals, is taken into cells, and affects insulin release in lab tests and live animals
cited by 1 paper
journal article
Jul '19
A Drug That Activates Two Hormone Receptors May Selectively Activate One Without Blocking Another
top 20% journal
cited by 24 papers
journal article